Medicare Enrolled

Dr. Casilda Balmaceda, M.D.

Neurology · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
710 W 168TH ST, New York, NY 10032
2123054572
In practice since 2006 (20 years)
NPI: 1093751919 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Balmaceda from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Balmaceda? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Balmaceda

Dr. Casilda Balmaceda is a neurology specialist in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Balmaceda performed 964 Medicare services across 621 unique beneficiaries.

Between the years covered by Open Payments, Dr. Balmaceda received a total of $161,693 from 80 pharmaceutical and/or device companies across 1479 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Balmaceda is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 29% volume in NY $161,693 industry payments

Medicare Practice Summary

Medicare Utilization ↗
964
Medicare services
Top 29% in NY for neurology
621
Unique beneficiaries
$109
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~48 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
351 $75 $141
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
124 $86 $300
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
83 $50 $140
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
63 $108 $225
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
61 $192 $400
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
60 $406 $600
Psychological test administration, first 30 minutes
A technician administers psychological or neuropsychological testing for the first 30 minutes.
60 $29 $75
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
41 $71 $100
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
35 $93 $225
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
30 $130 $250
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
19 $180 $300
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
19 $99 $165
Ultrasound of leg arteries or grafts
An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present.
18 $220 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$161,693
Total received (2018-2024)
Avg $23,099/year across 7 years
Top 5% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
1,479
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$136,216 (84.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,987 (14.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,491 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,237
2023
$4,390
2022
$17,312
2021
$29,050
2020
$25,593
2019
$61,152
2018
$18,960

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,166
MDD US Operations, LLC
$953
Abbott Laboratories
$641
Otsuka America Pharmaceutical, Inc.
$520
PFIZER INC.
$403
Biogen, Inc.
$244
UCB, Inc.
$240
Amneal Pharmaceuticals LLC
$236
SCILEX PHARMACEUTICALS INC.
$232
Kyowa Kirin, Inc.
$97
Eisai Inc.
$90
ARGENX US, INC.
$81
Lilly USA, LLC
$78
Medtronic, Inc.
$56
Novartis Pharmaceuticals Corporation
$41
Neurelis, Inc.
$39
Vanda Pharmaceuticals Inc.
$30
Boston Scientific Corporation
$28
Alexion Pharmaceuticals, Inc.
$27
Lundbeck LLC
$18
SK Life Science, Inc.
$14
Top 3 companies account for 52.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$74,370
Biohaven Pharmaceuticals, Inc.
$15,997
Allergan, Inc.
$11,325
EMD Serono, Inc.
$10,557
Biohaven Pharmaceutical Holding Company Ltd.
$9,679
AbbVie Inc.
$8,793
ABBVIE INC.
$4,242
Lilly USA, LLC
$3,194
Abbott Laboratories
$3,086
Kyowa Kirin, Inc.
$2,441
Amneal Pharmaceuticals LLC
$2,071
MDD US Operations, LLC
$1,683
UCB, Inc.
$1,638
RedHill Biopharma Inc.
$1,065
Otsuka America Pharmaceutical, Inc.
$818
PFIZER INC.
$743
Assertio Therapeutics, Inc.
$620
Eisai Inc.
$533
Allergan Inc.
$519
US WorldMeds, LLC
$487
Lundbeck LLC
$468
Biogen, Inc.
$462
SK Life Science, Inc.
$424
Novartis Pharmaceuticals Corporation
$394
Acorda Therapeutics, Inc
$349
Celgene Corporation
$292
Medtronic, Inc.
$274
Daiichi Sankyo Inc.
$262
Avion Pharmaceuticals
$250
EISAI INC.
$245
SCILEX PHARMACEUTICALS INC.
$232
Takeda Pharmaceuticals U.S.A., Inc.
$222
CMP Pharma, Inc.
$221
Supernus Pharmaceuticals, Inc.
$216
Boston Scientific Corporation
$214
Horizon Pharma plc
$206
Janssen Pharmaceuticals, Inc
$198
Avanir Pharmaceuticals, Inc.
$179
Sunovion Pharmaceuticals Inc.
$164
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$147
GE Healthcare
$145
Scilex Pharmaceuticals Inc.
$143
Promius Pharma LLC
$136
E.R. Squibb & Sons, L.L.C.
$125
Neurelis, Inc.
$117
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$116
Vertical Pharmaceuticals, LLC
$111
Impax Laboratories, Inc.
$111
Bausch Health US, LLC
$106
CSL Behring
$101
ARGENX US, INC.
$81
Alexion Pharmaceuticals, Inc.
$80
IDORSIA PHARMACEUTICALS US INC
$75
Ironwood Pharmaceuticals, Inc
$72
Corium, LLC
$67
Teva Pharmaceuticals USA, Inc.
$63
Currax Pharmaceuticals LLC
$60
Flowonix Medical Incorporated
$59
Adamas Pharmaceuticals, Inc.
$58
GE HEALTHCARE
$50
ACADIA Pharmaceuticals Inc
$49
Shionogi Inc
$42
Medtronic USA, Inc.
$37
Neurocrine Biosciences, Inc.
$32
Vanda Pharmaceuticals Inc.
$30
Esperion Therapeutics, Inc.
$29
Horizon Therapeutics plc
$29
Purdue Pharma L.P.
$28
Forte Bio-Pharma LLC
$28
GRT US Holding, Inc.
$27
Alnylam Pharmaceuticals Inc.
$26
MITSUBISHI TANABE PHARMA AMERICA, INC.
$25
Synergy Pharmaceuticals Inc
$24
Upsher-Smith Laboratories LLC
$22
Nevro Corp.
$20
Almatica Pharma LLC
$20
Azurity Pharmaceuticals, Inc.
$20
Arbor Pharmaceuticals, Inc.
$18
ARBOR PHARMACEUTICALS, INC.
$16
Mallinckrodt LLC
$14
Top 3 companies account for 62.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADASUVE · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · Aduhelm · Aimovig · Amitiza · Apokyn · Atorvaliq · BELBUCA · BOTOX · BOTOX COSMETIC · Briviact · CAMBIA · COMIRNATY · CONTRAVE · COPAXONE · CREXONT · CYMBALTA · Cambia · Carospir · DUEXIS · Dhivy · EMGALITY · Eprontia · Fycompa · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · Gocovri · HETLIOZ · Hizentra · Horizant · INBRIJA · INFINITY · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEQEMBI · LINZESS · LYRICA · LYVISPAH · Leqembi · Linzess · MIGRANAL · MOTEGRITY · Mavenclad · Morphabond ER · Movantik · NALOCET · NAMZARIC · NEXLETOL · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · None · Nourianz · Nuedexta · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · Ongentys · PAXLOVID · PERCEPT PC BRAINSENSE · Percept · Prometra II · QULIPTA · QUVIVIQ · Qutenza · RADICAVA · RAYOS · RELISTOR · REXULTI · RYTARY · Rebif · SKYCLARYS · SOLIRIS · SYMPROIC · Senza · Symproic · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · Trulance · UBRELVY · ULTOMIRIS · VALTOCO · VIIBRYD · VRAYLAR · VUMERITY · VYEPTI · VYVGART HYTRULO · Vimpat · XCOPRI · XIENCE SKYPOINT · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOMIG · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for neurology in NY.

Looking for a neurology specialist in New York?
Compare neurologists in the New York area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
1,287
Per 100K population
79.1
County median income
$104,553
Nearest hospital
NEW YORK STATE PSYCHIATRIC INSTITUTE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Balmaceda is a clinical cardiology specialist, with above-average Medicare volume (top 29% in NY), with speaking/promotional industry engagement in the top 5% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Balmaceda experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Balmaceda performed 351 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Balmaceda receive payments from pharmaceutical companies?
Yes. Dr. Balmaceda received a total of $161,693 from 80 companies across 1,479 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Balmaceda's costs compare to other neurologists in New York?
Dr. Balmaceda's average Medicare payment per service is $109. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Balmaceda) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →